Brooks Automation, a provider of automation, vacuum and instrumentation equipment for multiple markets, including semiconductor manufacturing, technology device manufacturing, and life sciences, is set to demerge its life sciences business into an independent and publicly-traded company. "This is an exciting day for Brooks and represents a critical milestone in our long-term strategy for the company. Over the past decade, we have successfully built two strong businesses in life sciences and automation. We are convinced the separation will better position each of them to extend their advantages in the markets they serve," Steve Schwartz, Brooks President and CEO.